Physical Training in Patients With Idiopathic Inflammatory Myopathies
NCT ID: NCT03092167
Last Updated: 2021-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2017-01-31
2021-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients
NCT00519103
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
NCT00341679
Adult and Juvenile Myositis
NCT00017914
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
NCT03324152
Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis
NCT00898989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Patients: this group will be submitted to 12-weeks, twice/week, physical exercises.
Physical exercises
Physical exercises
Control
Patients: this group will not be submitted to 12-weeks, twice/week, physical exercises.
No interventions assigned to this group
Healthy control
Volunteers: this group will not be submitted to 12-weeks, twice/week, physical exercises.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical exercises
Physical exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders and age ≥ 18 years
* Use of prednisone ≤ 0.5 mg/kg/day in the last three months. The dose of prednisone will be kept fixed throughout the study
* Physically inactive
Exclusion Criteria
* Neoplasia associated-myositis
* Overlapping myositis
* Use of lipid-lowering drugs
* Smoking
* Diabetes mellitus
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samuel Katsuyuki Shinjo, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel K Shinjo, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade de Sao Paulo - Rheumatology Division
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samuel Katsuyuki Shinjo
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Borges IBP, de Oliveira DS, Marie SKN, Lenario AM, Oba-Shinjo SM, Shinjo SK. Exercise Training Attenuates Ubiquitin-Proteasome Pathway and Increases the Genes Related to Autophagy on the Skeletal Muscle of Patients With Inflammatory Myopathies. J Clin Rheumatol. 2021 Sep 1;27(6S):S224-S231. doi: 10.1097/RHU.0000000000001721.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MYO-HCFMUSP-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.